Governance Documents

Investors

Overview
News & Events
Presentations
Company Info
Analyst Coverage
Financial Info
Stock Data
SEC Filings
SEDAR+
Legend Removal
Governance

Governance
Overview
Board of Directors
Board Committees
Governance Documents

Compensation Committee Charter

Download Compensation Committee Charter

Clawback Policy

Download Clawback Policy

Email Alerts
Contacts
RSS News Feed

Lexaria Bioscience Corp. (NASDAQ:LEXX) has developed and out-licenses its disruptive and cost-effective DehydraTECH™ technology that promotes healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules.

250.765.6424
info@lexariabioscience.com

Canadian Operations
#100-740 McCurdy Road
Kelowna, BC, V1X2P7

US Operations
105 Peach State Court, Suite A
Tyrone, GA 30290

General Disclaimer:
No statement in this web site has been evaluated by the Food and Drug Administration (FDA). Furthermore, none of the statements in this web site should be construed as dispensing medical advice or making claims regarding the cure of diseases…

Back to the top

Governance Documents

Code of Ethics

Audit Committee Charter

Compensation Committee Charter

Nominating Committee Charter

Employee Handbook

Clawback Policy